Recombinant Human NT-3 Protein 267-N3-005 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human NT-3 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $325.00Supplier Page View Company Product Page
Catalog Number267-N3-005
Size5 ug (also 25 ug)
FormatLyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein
Purity>97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining
ApplicationsBioactivity
Conjugate/TagUnconjugated
SpeciesHuman
Molecule NameNT-3
Molecular Weight13.7 kDa
Source/Expression SystemSf 21 (baculovirus)-derived Recombinant Human NT-3 Protein
NCBI Full Gene Nameneurotrophin 3
NCBI Gene AliasesNT3, NT-3, HDNF, NGF-2, NGF2
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Dysregulated Microglial Synaptic Engulfment in Diffuse Midline GliomaBIORXIVDecember 25, 2025Rebecca Mancusi, Eva Tatlock, Kiarash Shamardani, Lehi Acosta-Alvarez, Richard Drexler, Vrunda Trivedi, Avishai Gavish, Kouta Niizuma, Neeraj Soni, Pamelyn Woo, et al.Powder",Sigma-Aldrich,D9891-1G Recombinant Human BDNF Protein,R&D Systems,248-BDB-005 Recombinant Human NT-3 Protein,R&D Systems,267-N3-005 STD Human Rec Insulin 5 mg/ml 20ml,Lonza,BE02-033E20 Recombinant Human IL-34 (carrier-free) 10 μg,BioLegend,577902 "Recombinant Human IL-6

(2) Early developmental origins of cortical disorders modeled in human neural stem cellsNature communicationsJuly 9, 2025Mato-Blanco X, Kim SK, Jourdon A, Ma S, Choi SH, Giani AM, Paredes MI, Tebbenkamp ATN, Liu F, Duque A, et al.

(3) Patterning effects of FGF17 and cAMP on generation of dopaminergic progenitors for cell replacement therapy in Parkinson’s diseaseStem CellsMarch 12, 2025Amalie Holm Nygaard, Alrik L Schörling, Zehra Abay-Nørgaard, Erno Hänninen, Yuan Li, Adrian Ramón Santonja, Gaurav Singh Rathore, Alison Salvador, Charlotte Rusimbi, Katrine Bech Lauritzen, et al.#CP 673451 5993/10), PDGFC 1 µg/mL (R&D Systems, #1687-CC-025) or NT-3 10 or 20 ng/mL (R&D Systems, #267-N3-005) on top of FGF8b 100 ng/mL from days 9 to 16. Analysis was performed at days 16 and 42. In experiments

(4) Mapping the developmental trajectory of human astrocytes reveals divergence in glioblastomaNature cell biologyFebruary 1, 2025Sojka C, Wang HV, Bhatia TN, Li Y, Chopra P, Sing A, Voss A, King A, Wang F, Joseph K, et al.

(5) Specialized post-arterial capillaries facilitate adult bone remodellingNature cell biologyDecember 1, 2024Mohanakrishnan V, Sivaraj KK, Jeong HW, Bovay E, Dharmalingam B, Bixel MG, Dinh VV, Petkova M, Paredes Ugarte I, Kuo YT, et al.

(6) Saxitoxin potentiates human neuronal cell death induced by Zika virus while sparing neural progenitors and astrocytesScientific reportsOctober 1, 2024Souza LRQ, Pedrosa CGDS, Puig-Pijuan T, da Silva Dos Santos C, Vitória G, Delou JMA, Setti-Perdigão P, Higa LM, Tanuri A, Rehen SK, et al.

(7) Axon-derived PACSIN1 binds to the Schwann cell survival receptor, LRP1, and transactivates TrkC to promote gliatrophic activitiesGliaMay 1, 2024Martellucci S, Flütsch A, Carter M, Norimoto M, Pizzo D, Mantuano E, Sadri M, Wang Z, Chillin-Fuentes D, Rosenthal SB, et al.proteins, including PACSIN1 (#C834, Bon Opus Biosciences, Millburn, NJ, USA); Neurotrophin-3 (NT-3) (#267-N3-005, R&D System, Minneapolis, USA) or Neuregulin 1 (NRG1) (#9875-NR-050, R&D System, Minneapolis, USA).

(8) A branching model of lineage differentiation underpinning the neurogenic potential of enteric gliaNature communicationsSeptember 22, 2023Laddach A, Chng SH, Lasrado R, Progatzky F, Shapiro M, Erickson A, Sampedro Castaneda M, Artemov AV, Bon-Frauches AC, Amaniti EM, et al.

(9) Identification of ligand-receptor pairs that drive human astrocyte developmentNature neuroscienceAugust 1, 2023Voss AJ, Lanjewar SN, Sampson MM, King A, Hill EJ, Sing A, Sojka C, Bhatia TN, Spangle JM, Sloan SA.

(10) IPSC-Derived Sensory Neurons Directing Fate Commitment of Human BMSC-Derived Schwann Cells: Applications in Traumatic Neural InjuriesCellsMay 25, 2023Tam KW, Wong CY, Wu KL, Lam G, Liang X, Wong WT, Li MT, Liu WY, Cai S, Shea GK, et al.

(11) Preclinical Studies with Glioblastoma Brain Organoid Co-Cultures Show Efficient 5-ALA Photodynamic TherapyCellsApril 10, 2023Pedrosa L, Bedia C, Diao D, Mosteiro A, Ferrés A, Stanzani E, Martínez-Soler F, Tortosa A, Pineda E, Aldecoa I, et al.

(12) Pervasive environmental chemicals impair oligodendrocyte developmentbioRxiv : the preprint server for biologyFebruary 12, 2023Cohn EF, Clayton BLL, Madhavan M, Yacoub S, Federov Y, Paul-Friedman K, Shafer TJ, Tesar PJ.

(13) Stem cell-nanomedicine system as a theranostic bio-gadolinium agent for targeted neutron capture cancer therapyNature communicationsJanuary 18, 2023Lai YH, Su CY, Cheng HW, Chu CY, Jeng LB, Chiang CS, Shyu WC, Chen SY.

(14) Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironmentNature communicationsAugust 26, 2022Tang Y, Kwiatkowski DJ, Henske EP.

(15) Oligodendrocyte differentiation alters tRNA modifications and codon optimality-mediated mRNA decayNature communicationsAugust 25, 2022Martin S, Allan KC, Pinkard O, Sweet T, Tesar PJ, Coller J.

(16) Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutationScientific reportsJuly 25, 2022Sawamura M, Imamura K, Hikawa R, Enami T, Nagahashi A, Yamakado H, Ichijo H, Fujisawa T, Yamashita H, Minamiyama S, et al.

(17) Physical and functional interactome atlas of human receptor tyrosine kinasesEMBO reportsJune 7, 2022Salokas K, Liu X, Öhman T, Chowdhury I, Gawriyski L, Keskitalo S, Varjosalo M.

(18) Phoenix auditory neurons as 3R cell model for high throughput screening of neurogenic compoundsHearing researchFebruary 1, 2022Rousset F, Schmidbauer D, Fink S, Adel Y, Obexer B, Müller M, Glueckert R, Löwenheim H, Senn P.

(19) Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial DiseasesFrontiers in pharmacologyJanuary 1, 2022Suárez-Rivero JM, Pastor-Maldonado CJ, Romero-González A, Gómez-Fernandez D, Povea-Cabello S, Álvarez-Córdoba M, Villalón-García I, Talaverón-Rey M, Suárez-Carrillo A, Munuera-Cabeza M, et al.

(20) Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1PloS oneJanuary 1, 2022Eltahir MK, Nakamori M, Hattori S, Kimura T, Mochizuki H, Nagano S.

Be the First to Write a Review!

NT-3 Protein

NT-3 Protein

NT-3 Protein

NT-3 Protein

Recombinant Human NT-3 Protein from R&D Systems, a Bio-Techne Brand

Description

R&D Systems, a Bio-Techne Brand

Citations (81)

Reviews

Recombinant Human NT-3 Protein from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map